Society questions European report

WP_Post Object
(
    [ID] => 12531
    [post_author] => 5
    [post_date] => 2017-10-05 14:02:34
    [post_date_gmt] => 2017-10-05 14:02:34
    [post_content] => 

The Society of Homeopaths has questioned a recent report on homeopathy products and practices by the European Academies and Science Advisory Council (EASAC).

The statement questions much of the principles and practice of homeopathy but contains little that is new and is mostly a selective use of negative research, much of which has long been discredited.

Zofia Dymitr, the Society’s representative on the European Central Council of Homeopaths (ECCH) and ECCH Vice Chair comments:

‘EASAC is not an official EU body and this report was not commissioned by the European Parliament.  If the purpose was to influence policy, EASAC should have considered existing evidence widely available and consulted with stakeholder organizations like ECCH, the European Committee for Homeopathy (ECH) and the Homeopathy Research Institute.  This they have failed to do. Instead they seem to have reinforced their own bias against homeopathy by referencing already discredited reports’

Leading homeopaths and organisations in the UK and around Europe have questioned the report and its processes.  These include the Homeopathy Research Institute, the British Homeopathic Association, the German Pharmaceutical industry trade body (BPI) and Peter Fisher, Clinical Director and Director of Research at the Royal London Hospital for Integrated Medicine

Zofia Dymitr confirmed that the Society would collaborate with other organisations across Europe to agree a joint strategy to counter this report.

Links to the EASAC report and responses: EASAC Homeopathy statement HRI Statement  BHA response Peter Fisher response BPI Position on EASAC Publication   [post_title] => Society questions European report [post_excerpt] => [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => society-questions-european-report [to_ping] => [pinged] => [post_modified] => 2017-10-06 09:09:06 [post_modified_gmt] => 2017-10-06 09:09:06 [post_content_filtered] => [post_parent] => 0 [guid] => https://homeopathy-soh.org/?p=12531 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw )

The Society of Homeopaths has questioned a recent report on homeopathy products and practices by the European Academies and Science Advisory Council (EASAC).

The statement questions much of the principles and practice of homeopathy but contains little that is new and is mostly a selective use of negative research, much of which has long been discredited.

Zofia Dymitr, the Society’s representative on the European Central Council of Homeopaths (ECCH) and ECCH Vice Chair comments:

‘EASAC is not an official EU body and this report was not commissioned by the European Parliament.  If the purpose was to influence policy, EASAC should have considered existing evidence widely available and consulted with stakeholder organizations like ECCH, the European Committee for Homeopathy (ECH) and the Homeopathy Research Institute.  This they have failed to do. Instead they seem to have reinforced their own bias against homeopathy by referencing already discredited reports’

Leading homeopaths and organisations in the UK and around Europe have questioned the report and its processes.  These include the Homeopathy Research Institute, the British Homeopathic Association, the German Pharmaceutical industry trade body (BPI) and Peter Fisher, Clinical Director and Director of Research at the Royal London Hospital for Integrated Medicine

Zofia Dymitr confirmed that the Society would collaborate with other organisations across Europe to agree a joint strategy to counter this report.

Links to the EASAC report and responses:

EASAC Homeopathy statement

HRI Statement 

BHA response

Peter Fisher response

BPI Position on EASAC Publication

 

Share this page